Can-Fite BioPharma Ltd - Rasio nilai perusahaan marang dodolan CANF

Simbol resmi perusahaan canfite.com (CANF)

Can-Fite BioPharma (CANF) relies on an asset-light model, delegating molecule synthesis to external contractors. The development strategy is based on licensing agreements with distributors worldwide and the monetization of patents through out-licensing. An enterprise valuation using EV/Sales helps identify the true trend within the sideways corridor, with the current value equal to -5804.88.

Can-Fite (CANF): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Can-Fite BioPharma, Ltd. - rincian analitis lan metrik utama (CANF)

Pambiji fundamental perusahaan:CANF, canfite.com
Produk sing diprodhuksi Can-Fite BioPharma Ltd

This indicator determines the business value relative to its revenue, excluding the impact of debt load to provide an objective assessment of fundamental value. By analyzing the current EV/Sales level, an investor can see to what extent the market price of Can-Fite BioPharma (CANF) is justified by revenues, while the expected results of final clinical trials for liver disease drugs could serve as a key trigger for a revision of this multiple.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|BLRX (BioLineRx) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales